This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• B of A Securities analyst Jason Gerberry downgraded ProKidney Corp. (NASDAQ:PROK) from Neutral to Underperform and lowered the price target from $3 to $1. ProKidney shares closed at $0.6687 on Friday. See how other analysts view this stock.
• D. Boral Capital analyst Jason Kolbert downgraded the rating for CorMedix Inc. (NASDAQ:CRMD) from Buy to Hold. Cormedix shares closed at $12.50 on Friday. See how other analysts view this stock.
• BMO Capital analyst John McNulty downgraded Tronox Holdings plc (NYSE:TROX) from Market Perform to Underperform and lowered the price target from $7 to $3. Tronox Holdings shares closed at $5.64 on Friday. See how other analysts view this stock.

Considering buying CRMD stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Just Revealed 1 Oil Stock He Actually Wants To Own

Photo via Shutterstock